Guszczyn, T.; Kulesza, M.; Maciąg, G.; Kicman, A.; Ławicki, S.
The Effectiveness of Treating Osgood–Schlatter Disease (OSD) with Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) Depending on the Duration of the Disease. J. Clin. Med. 2024, 13, 4220.
https://doi.org/10.3390/jcm13144220
AMA Style
Guszczyn T, Kulesza M, Maciąg G, Kicman A, Ławicki S.
The Effectiveness of Treating Osgood–Schlatter Disease (OSD) with Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) Depending on the Duration of the Disease. Journal of Clinical Medicine. 2024; 13(14):4220.
https://doi.org/10.3390/jcm13144220
Chicago/Turabian Style
Guszczyn, Tomasz, Monika Kulesza, Grzegorz Maciąg, Aleksandra Kicman, and Sławomir Ławicki.
2024. "The Effectiveness of Treating Osgood–Schlatter Disease (OSD) with Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) Depending on the Duration of the Disease" Journal of Clinical Medicine 13, no. 14: 4220.
https://doi.org/10.3390/jcm13144220
APA Style
Guszczyn, T., Kulesza, M., Maciąg, G., Kicman, A., & Ławicki, S.
(2024). The Effectiveness of Treating Osgood–Schlatter Disease (OSD) with Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) Depending on the Duration of the Disease. Journal of Clinical Medicine, 13(14), 4220.
https://doi.org/10.3390/jcm13144220